109 related articles for article (PubMed ID: 16410665)
1. Effects of dehydroepiandrosterone on gluconeogenic enzymes and glucose uptake in human hepatoma cell line, HepG2.
Yamashita R; Saito T; Satoh S; Aoki K; Kaburagi Y; Sekihara H
Endocr J; 2005 Dec; 52(6):727-33. PubMed ID: 16410665
[TBL] [Abstract][Full Text] [Related]
2. Dehydroepiandrosterone suppresses elevated hepatic glucose-6-phosphatase mRNA level in C57BL/KsJ-db/db mice: comparison with troglitazone.
Aoki K; Kikuchi T; Mukasa K; Ito S; Nakajima A; Satoh S; Okamura A; Sekihara H
Endocr J; 2000 Dec; 47(6):799-804. PubMed ID: 11228057
[TBL] [Abstract][Full Text] [Related]
3. Dehydroepiandrosterone decreases elevated hepatic glucose production in C57BL/KsJ-db/db mice.
Aoki K; Taniguchi H; Ito Y; Satoh S; Nakamura S; Muramatsu K; Yamashita R; Ito S; Mori Y; Sekihara H
Life Sci; 2004 May; 74(25):3075-84. PubMed ID: 15081573
[TBL] [Abstract][Full Text] [Related]
4. Dehydroepiandrosterone suppresses the elevated hepatic glucose-6-phosphatase and fructose-1,6-bisphosphatase activities in C57BL/Ksj-db/db mice: comparison with troglitazone.
Aoki K; Saito T; Satoh S; Mukasa K; Kaneshiro M; Kawasaki S; Okamura A; Sekihara H
Diabetes; 1999 Aug; 48(8):1579-85. PubMed ID: 10426376
[TBL] [Abstract][Full Text] [Related]
5. DHEA-induced modulation of renal gluconeogenesis, insulin sensitivity and plasma lipid profile in the control- and dexamethasone-treated rabbits. Metabolic studies.
Kiersztan A; Nagalski A; Nalepa P; Tempes A; Trojan N; Usarek M; Jagielski AK
Biochimie; 2016 Feb; 121():87-101. PubMed ID: 26616007
[TBL] [Abstract][Full Text] [Related]
6. Metformin-induced suppression of glucose-6-phosphatase expression is independent of insulin signaling in rat hepatoma cells.
Morioka K; Nakatani K; Matsumoto K; Urakawa H; Kitagawa N; Katsuki A; Hori Y; Gabazza EC; Yano Y; Nishioka J; Nobori T; Sumida Y; Adachi Y
Int J Mol Med; 2005 Mar; 15(3):449-52. PubMed ID: 15702236
[TBL] [Abstract][Full Text] [Related]
7. Sodium arsenite induces orphan nuclear receptor SHP gene expression via AMP-activated protein kinase to inhibit gluconeogenic enzyme gene expression.
Chanda D; Kim SJ; Lee IK; Shong M; Choi HS
Am J Physiol Endocrinol Metab; 2008 Aug; 295(2):E368-79. PubMed ID: 18505831
[TBL] [Abstract][Full Text] [Related]
8. Dehydroepiandrosterone-induced changes in mitochondrial proteins contribute to phenotypic alterations in hepatoma cells.
Cheng ML; Chi LM; Wu PR; Ho HY
Biochem Pharmacol; 2016 Oct; 117():20-34. PubMed ID: 27501919
[TBL] [Abstract][Full Text] [Related]
9. The regulation of glucose-6-phosphatase and phosphoenolpyruvate carboxykinase by autophagy in low-glycolytic hepatocellular carcinoma cells.
Jeon JY; Lee H; Park J; Lee M; Park SW; Kim JS; Lee M; Cho B; Kim K; Choi AM; Kim CK; Yun M
Biochem Biophys Res Commun; 2015 Jul; 463(3):440-6. PubMed ID: 26036577
[TBL] [Abstract][Full Text] [Related]
10. Effects of a catechin-free fraction derived from green tea on gene expression of gluconeogenic enzymes in rat hepatoma H4IIE cells and in the mouse liver.
Yasui K; Miyoshi N; Tanabe H; Ishigami Y; Fukutomi R; Imai S; Isemura M
Biomed Res; 2011 Apr; 32(2):119-25. PubMed ID: 21551947
[TBL] [Abstract][Full Text] [Related]
11. Aldosterone stimulates gene expression of hepatic gluconeogenic enzymes through the glucocorticoid receptor in a manner independent of the protein kinase B cascade.
Yamashita R; Kikuchi T; Mori Y; Aoki K; Kaburagi Y; Yasuda K; Sekihara H
Endocr J; 2004 Apr; 51(2):243-51. PubMed ID: 15118277
[TBL] [Abstract][Full Text] [Related]
12. Irisin inhibits hepatic gluconeogenesis and increases glycogen synthesis via the PI3K/Akt pathway in type 2 diabetic mice and hepatocytes.
Liu TY; Shi CX; Gao R; Sun HJ; Xiong XQ; Ding L; Chen Q; Li YH; Wang JJ; Kang YM; Zhu GQ
Clin Sci (Lond); 2015 Nov; 129(10):839-50. PubMed ID: 26201094
[TBL] [Abstract][Full Text] [Related]
13. Negative regulation of hepatic fat mass and obesity associated (Fto) gene expression by insulin.
Mizuno TM; Lew PS; Luo Y; Leckstrom A
Life Sci; 2017 Feb; 170():50-55. PubMed ID: 27914922
[TBL] [Abstract][Full Text] [Related]
14. Prevention of diabetes, hepatic injury, and colon cancer with dehydroepiandrosterone.
Aoki K; Nakajima A; Mukasa K; Osawa E; Mori Y; Sekihara H
J Steroid Biochem Mol Biol; 2003 Jun; 85(2-5):469-72. PubMed ID: 12943737
[TBL] [Abstract][Full Text] [Related]
15. Evidence for an indirect transcriptional regulation of glucose-6-phosphatase gene expression by liver X receptors.
Grempler R; Günther S; Steffensen KR; Nilsson M; Barthel A; Schmoll D; Walther R
Biochem Biophys Res Commun; 2005 Dec; 338(2):981-6. PubMed ID: 16256938
[TBL] [Abstract][Full Text] [Related]
16. DYRK1 is a co-activator of FKHR (FOXO1a)-dependent glucose-6-phosphatase gene expression.
von Groote-Bidlingmaier F; Schmoll D; Orth HM; Joost HG; Becker W; Barthel A
Biochem Biophys Res Commun; 2003 Jan; 300(3):764-9. PubMed ID: 12507516
[TBL] [Abstract][Full Text] [Related]
17. Effect of dehydroepiandrosterone on glucose uptake in cultured rat myoblasts.
Nakashima N; Haji M; Umeda F; Nawata H
Horm Metab Res; 1995 Nov; 27(11):491-4. PubMed ID: 8770624
[TBL] [Abstract][Full Text] [Related]
18. Activities of key gluconeogenic enzymes and glycogen synthase in rat and human livers, hepatomas, and hepatoma cell cultures.
Hammond KD; Balinsky D
Cancer Res; 1978 May; 38(5):1317-22. PubMed ID: 205362
[TBL] [Abstract][Full Text] [Related]
19. Effect of dehydroepiandrosterone on glucose uptake in cultured human fibroblasts.
Nakashima N; Haji M; Sakai Y; Ono Y; Umeda F; Nawata H
Metabolism; 1995 Apr; 44(4):543-8. PubMed ID: 7723680
[TBL] [Abstract][Full Text] [Related]
20. Tumour necrosis factor-alpha attenuates insulin action on phosphoenolpyruvate carboxykinase gene expression and gluconeogenesis by altering the cellular localization of Foxa2 in HepG2 cells.
Pandey AK; Bhardwaj V; Datta M
FEBS J; 2009 Jul; 276(14):3757-69. PubMed ID: 19769745
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]